Showing results (141-150 of 251) with videos related to
Sort By:
Pageof 26
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 15, 2013
Prevalence and lifetime risk of endoscopy-related complications among patients with inflammatory bowel diseaseJason Ferreira, Mona Akbari, Laurie Gashin, et al.Inflammatory Bowel Diseases|September 6, 2014
Proactive therapeutic concentration monitoring of infliximab may improve outcomes for patients with inflammatory bowel disease: results from a pilot observational studyByron P Vaughn, Manuel Martinez-Vazquez, Vilas R Patwardhan, et al.Alimentary Pharmacology & Therapeutics|October 23, 2025
Maternal and Perinatal Outcomes in Pregnant Women With Comorbid Inflammatory Bowel Disease and Chronic Liver DiseaseJessica D Lee, Konstantinos Papamichael, Lauren T Grinspan, et al.Inflammatory Bowel Diseases|June 8, 2011
Abdominal phlegmons in Crohn's disease: outcomes following antitumor necrosis factor therapyGarret Cullen, Byron Vaughn, Awais Ahmed, et al.Journal of Clinical Gastroenterology|March 15, 2016
Utility of Emergency Department Use of Abdominal Pelvic Computed Tomography in the Management of Crohn's DiseaseJenna Koliani-Pace, Byron Vaughn, Shoshana J Herzig, et al.European Journal of Gastroenterology & Hepatology|September 2, 2022
Efficacy and safety of biologic therapy in microscopic colitis: systematic review and meta-analysisVikas Taneja, Mohammed El-Dallal, Rajsavi S Anand, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 3, 2017
Improved Long-term Outcomes of Patients With Inflammatory Bowel Disease Receiving Proactive Compared With Reactive Monitoring of Serum Concentrations of InfliximabKonstantinos Papamichael, Karen A Chachu, Ravy K Vajravelu, et al.Expert Review of Clinical Pharmacology|February 11, 2026
Therapeutic drug monitoring for de-escalating anti-tumor necrosis factor therapy in patients with inflammatory bowel diseaseAjay Gade, Alessandra Saraga, Alfonso Elosua, et al.Journal of Crohn'S & Colitis|February 18, 2020
Is Therapeutic Drug Monitoring for Anti-tumour Necrosis Factor Agents in Adults With Inflammatory Bowel Disease Ready for Standard of Care? A Systematic Review and Meta-analysisRaj Shah, Gila R Hoffman, Mohammed El-Dallal, et al.Crohn'S & Colitis 360|February 13, 2023
Increased Mortality and Healthcare Costs Upon Hospital Readmissions of Ulcerative Colitis Flares: A Large Population-Based Cohort StudySimcha Weissman, Sachit Sharma, Brian M Fung, et al.Pageof 26